Market Cap:
$ SEC Filings
| Filing | Filed On |
|---|---|
| 25-NSE | 21 Dec 2022 |
| 8-K | 02 Dec 2022 |
| 8-K | 23 Nov 2022 |
| NT 10-Q | 15 Nov 2022 |
| 8-K | 08 Nov 2022 |
| NEW ENTERPRISE ASSOCIATES 13, LP (PHASEBIO PHARMACEUTICALS) - SCHEDULE 13D/A#1E | 04 Nov 2022 |
| 8-K | 31 Oct 2022 |
| FORM 4 SUBMISSION | 26 Oct 2022 |
| 8-K | 24 Oct 2022 |
| 8-K | 07 Oct 2022 |
| 8-K | 27 Sep 2022 |
| 10-Q | 12 Aug 2022 |
| 8-K | 12 Aug 2022 |
| 8-K | 08 Aug 2022 |
| SC 13G/A | 19 Jul 2022 |
| 8-K | 05 Jul 2022 |
| FORM 4/A | 10 Jun 2022 |
| FORM 4 | 24 May 2022 |
| FORM 4 | 24 May 2022 |
| FORM 4 | 24 May 2022 |
